Approximately USD 8 Million Investment for New Vaccine and Drug Development Against Malaria in Sumitomo Pharma, Mitsubishi Tanabe Pharma and New Product Development in NTDs ...Middle East

TOKYO, Sept. 27, 2023 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately 907 million yen (US$6.2 million1) for the development of a new prophylactic vaccine against malaria and a new anti-malarial drug and approximately 273...

Hence then, the article about approximately usd 8 million investment for new vaccine and drug development against malaria in sumitomo pharma mitsubishi tanabe pharma and new product development in ntds was published today ( Wednesday 27/09/2023 - 08:08 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Approximately USD 8 Million Investment for New Vaccine and Drug Development Against Malaria in Sumitomo Pharma, Mitsubishi Tanabe Pharma and New Product Development in NTDs )

Also on site :

• Video: What we know about Israel’s assault on southern Lebanon
• Sarah Michelle Gellar reveals who’s to blame for ‘Buffy’ reboot cancellation
• Psiquiatras podrían adoptar biomarcadores en el diagnóstico de la salud mental